For citations:
Dronova T.A., Babyshkina N.N., Zavyalova M.V., Patalyak S.V., Slonimskaya E.M., Cherdyntseva N.V., Kzhyshkowska J.G. Relation of EGFR/PI3K/AKT signaling components with tamoxifen efficacy in patients with estrogen-dependent breast cancer. Advances in Molecular Oncology. 2018;5(3):40-50. (In Russ.) https://doi.org/10.17650/2313-805X-2018-5-3-40-50
Email this article 